Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer

• Main Authors: Jens Cardinale (Author), René Martin (Author), Yvonne Remde (Author), Martin Schäfer (Author), Antje Hienzsch (Author), Sandra Hübner (Author), Anna-Maria Zerges (Author), Heike Marx (Author), Ronny Hesse (Author), Klaus Weber (Author), Rene Smits (Author), Alexander Hoepping (Author), Marco Müller (Author), Oliver C. Neels (Author), Klaus Kopka (Author)
• Format: Book
• Published: MDPI AG, 2017-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Radiolabeled tracers targeting the prostate-specific membrane antigen (PSMA) have become important radiopharmaceuticals for the PET-imaging of prostate cancer. In this connection, we recently developed the fluorine-18-labelled PSMA-ligand [18F]PSMA-1007 as the next generation radiofluorinated Glu-ur...